Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.34 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.30 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.30 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14562495 | 0.74 | HCAR2 (0.34) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| SCHEMBL1553635 | 0.73 | CYP3A4 (0.40) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| SCHEMBL19716782 | 0.71 | MAPT (0.41) | LMNA | |
| SCHEMBL2371326 | 0.70 | AKR1C3 (0.38) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| SCHEMBL31214086 | 0.70 | CYP11B1 (0.39) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| SCHEMBL30338528 | 0.69 | ADORA3 (0.36) | RPS6KB1 | |
| SCHEMBL2371309 | 0.69 | CYP3A4 (0.36) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| Potassium Ion SCHEMBL2370572 | 0.69 | CYP3A4 (0.36) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| Lithium Ion SCHEMBL2370296 | 0.69 | CYP3A4 (0.36) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 | |
| SCHEMBL2625489 | 0.69 | CYP11B1 (0.40) | CYP3A4CYP2C9CYP2B6CYP3A5CYP3A7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116547281-A | Isoxazolidines as RIPK1 inhibitors and uses thereof | 赛诺菲 | 2023-08-04 | — | — | CN | disclosed |